Risperidone
Showing 26 - 50 of 708
Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy Trial in Toronto (Risperidone, Olanzapine)
Recruiting
- Schizophrenia and Related Disorders
- +3 more
- Risperidone
- Olanzapine
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jul 20, 2022
Striatal Connectivity and Clinical Outcome in Psychosis
Recruiting
- Psychotic Disorders
- Risperidone or Aripiprazole (patients only)
-
Glen Oaks, New YorkZucker Hillside Hospital
Jan 24, 2022
Breakthrough Symptoms With Long-Acting Injectable Medications
Not yet recruiting
- Schizophrenia
- Schizophrenia Relapse
- Second Generation Long-Acting Injectable Antipsychotic Medications
- (no location specified)
Jul 22, 2022
Schizophrenia Trial (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))
Not yet recruiting
- Schizophrenia
- SEP-363856
- Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
- (no location specified)
Sep 13, 2022
Autism Spectrum Disorder Trial in Rotterdam (Therapeutic Drug Monitoring, Risperidone plasma level)
Recruiting
- Autism Spectrum Disorder
- Therapeutic Drug Monitoring
- Risperidone plasma level
-
Rotterdam, NetherlandsErasmus Medical Center
Nov 23, 2021
Schizophrenia, Schizoaffective Disorder, Bipolar 1 Disorder Trial in Dallas (clozapine, risperidone)
Recruiting
- Schizophrenia
- +2 more
- clozapine
- risperidone
-
Dallas, TexasUT Southwestern Medical Center
Feb 22, 2022
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (Risperidone/Olanzapine and PET scans)
Completed
- Schizophrenia
- +4 more
- Risperidone/Olanzapine and PET scans
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jun 2, 2022
Opioid Abuse, Unspecified, Opioid Dependence Trial in San Antonio (Oxycodone/Placebo, Oxycodone/Risperidone,
Terminated
- Opioid Abuse, Unspecified
- Opioid Dependence
- Oxycodone/Placebo
- +2 more
-
San Antonio, TexasWestgate Pain Clinic
Jan 31, 2022
Autism Spectrum Disorder Trial in Tehran (RisperiDONE 1 MG/ML, transcranial direct current stimulation, Placebo)
Active, not recruiting
- Autism Spectrum Disorder
- RisperiDONE 1 MG/ML
- +3 more
-
Tehran, Iran, Islamic Republic ofThe National Brain Mapping Laboratory (NBML)
Aug 5, 2022
Schizophrenia Spectrum and Other Psychotic Disorders Trial in New York (Risperidone)
Recruiting
- Schizophrenia Spectrum and Other Psychotic Disorders
- Risperidone
-
New York, New YorkNew York State Psychiatric Institute & Columbia University
Jul 28, 2022
Velocardiofacial Syndrome, Williams Syndrome, Fragile X Syndrome Trial in Petach-Tikva (methylphenidate, fluoxetin, risperidone)
Recruiting
- Velocardiofacial Syndrome
- +2 more
- methylphenidate, fluoxetin, risperidone
-
Petach-Tikva, IsraelSchneider Children's Mediac Center of Israel
Mar 8, 2022
Schizophrenia Trial in Rwanda (Risperidone 3 mg, Paliperidone Palmitate 50 mg eq., Paliperidone Palmitate 75 mg eq.)
Recruiting
- Schizophrenia
- Risperidone 3 mg
- +8 more
-
Butare, Rwanda
- +4 more
Jan 3, 2023
Schizophrenia Relapse Trial (reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone,
Completed
- Schizophrenia Relapse
- reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone, levomepromazine, perphenazine
- (no location specified)
Aug 11, 2021
Schizophrenia Trial in United States (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))
Recruiting
- Schizophrenia
- SEP-363856
- Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
-
Little Rock, Arkansas
- +6 more
Nov 11, 2022
Dual Diagnosis Trial in Glostrup (Cannabidiol, Risperidone)
Recruiting
- Dual Diagnosis
- Cannabidiol
- Risperidone
-
Glostrup, DenmarkCenter for Neuropsychiatric Schizophrenia Research
Jun 7, 2021
Huntington Disease Trial in Hangzhou (Haloperidol 2Mg Tab, Risperidone 1Mg Tab, Zoloft 50Mg Tablet)
Recruiting
- Huntington Disease
- Haloperidol 2Mg Tab
- +4 more
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital,Zhejiang University School of Medicin
Mar 30, 2021
Bipolar Disorder Trial in Cincinnati, Milwaukee (Risperidone oral solution, Valproate Oral Solution, Placebo)
Completed
- Bipolar Disorder
- Risperidone oral solution
- +2 more
-
Cincinnati, Ohio
- +1 more
Sep 25, 2020
Schizophrenia Trial in Aizuwakamatsu (MP-214, Risperidone)
Schizophrenia Trial in Kettering (Aripiprazole, Risperidone)
Terminated
- Schizophrenia
- Aripiprazole
- Risperidone
-
Kettering, OhioWallace Kettering Neuroscience Institute
Jul 10, 2020
Schizophrenia Trial in Kigali, Musanze District, Ngoma District (Risperidone 3 mg, Paliperidone Palmitate 50 mg eq.,
Completed
- Schizophrenia
- Risperidone 3 mg
- +8 more
-
Kigali, Rwanda
- +2 more
Nov 13, 2020